Virtual Talk: Using Transferrin-Receptor Mediated Transcytosis as Mechanism for the First Approved Biotherapeutic Designed to Cross the Blood Brain Barrier

Time: 8:45 am
day: Day One


• Capturing the key translational aspects moving into human trials
• Defining moments on the path to approval
• Applicability of the technology across modalities and indications